1. Home
  2. EMBC vs DLY Comparison

EMBC vs DLY Comparison

Compare EMBC & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • DLY
  • Stock Information
  • Founded
  • EMBC 1924
  • DLY 2019
  • Country
  • EMBC United States
  • DLY United States
  • Employees
  • EMBC N/A
  • DLY N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • DLY Investment Managers
  • Sector
  • EMBC Health Care
  • DLY Finance
  • Exchange
  • EMBC Nasdaq
  • DLY Nasdaq
  • Market Cap
  • EMBC 726.8M
  • DLY 759.6M
  • IPO Year
  • EMBC N/A
  • DLY N/A
  • Fundamental
  • Price
  • EMBC $10.39
  • DLY $15.37
  • Analyst Decision
  • EMBC Hold
  • DLY
  • Analyst Count
  • EMBC 3
  • DLY 0
  • Target Price
  • EMBC $17.00
  • DLY N/A
  • AVG Volume (30 Days)
  • EMBC 688.2K
  • DLY 215.9K
  • Earning Date
  • EMBC 08-08-2025
  • DLY 01-01-0001
  • Dividend Yield
  • EMBC 5.72%
  • DLY 8.93%
  • EPS Growth
  • EMBC N/A
  • DLY N/A
  • EPS
  • EMBC 0.89
  • DLY N/A
  • Revenue
  • EMBC $1,079,500,000.00
  • DLY N/A
  • Revenue This Year
  • EMBC N/A
  • DLY N/A
  • Revenue Next Year
  • EMBC N/A
  • DLY N/A
  • P/E Ratio
  • EMBC $11.75
  • DLY N/A
  • Revenue Growth
  • EMBC N/A
  • DLY N/A
  • 52 Week Low
  • EMBC $9.20
  • DLY $13.26
  • 52 Week High
  • EMBC $21.48
  • DLY $15.95
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 50.88
  • DLY 37.61
  • Support Level
  • EMBC $9.97
  • DLY $15.45
  • Resistance Level
  • EMBC $10.87
  • DLY $15.59
  • Average True Range (ATR)
  • EMBC 0.45
  • DLY 0.10
  • MACD
  • EMBC 0.14
  • DLY -0.02
  • Stochastic Oscillator
  • EMBC 71.47
  • DLY 12.50

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

Share on Social Networks: